Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.

Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Resúmenes publicados
Búsqueda
Trastornos del movimiento Movement disorders 88 artículos Viendo del 1 al 40 de 88 artículos
Pub MED

Paroxysmal movement disorders - practical update on diagnosis and management.NUEVO

De Gusmao CM, Silveira-Moriyama L.
Expert Rev Neurother. 2019 Sep;19(9):807-822. doi: 10.1080/14737175.2019.1648211. Epub 2019 Aug 8.
Pub MED

Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders.NUEVO

Antonazzo M, Botta M, Bengoetxea H, Ruiz-Ortega JÁ, Morera-Herreras T.
Int Rev Neurobiol. 2019;146:229-257. doi: 10.1016/bs.irn.2019.06.012. Epub 2019 Jun 28.
Pub MED

Gabapentin for pain, movement disorders, and irritability in neonates and infants.NUEVO

Burnsed JC, Heinan K, Letzkus L, Zanelli S.
Dev Med Child Neurol. 2019 Jul 25. doi: 10.1111/dmcn.14324. [Epub ahead of print]
Pub MED

The interindividual variability of transcranial magnetic stimulation effects: Implications for diagnostic use in movement disorders.NUEVO

Latorre A, Rocchi L, Berardelli A, Bhatia KP, Rothwell JC.
Mov Disord. 2019 Jul;34(7):936-949. doi: 10.1002/mds.27736. Epub 2019 Jun 10. Review.
Pub MED

Cognition and Evolution of Movement Disorders of FOXG1-Related Syndrome.NUEVO

Wong LC, Wu YT, Hsu CJ, Weng WC, Tsai WC, Lee WT.
Front Neurol. 2019 Jun 28;10:641. doi: 10.3389/fneur.2019.00641. eCollection 2019.
Pub MED

Patient Experience with Rechargeable Implantable Pulse Generator Deep Brain Stimulation for Movement Disorders.NUEVO

Mitchell KT, Volz M, Lee A, San Luciano M, Wang S, Starr PA, Larson P, Galifianakis NB, Ostrem JL.
Stereotact Funct Neurosurg. 2019;97(2):113-119. doi: 10.1159/000500993. Epub 2019 Jul 9.
Pub MED

Antisense therapies for movement disorders.NUEVO

Scoles DR, Pulst SM.
Mov Disord. 2019 Aug;34(8):1112-1119. doi: 10.1002/mds.27782. Epub 2019 Jul 8. Review.
Pub MED

Recent developments in drug-induced movement disorders: a mixed picture.NUEVO

Factor SA, Burkhard PR, Caroff S, Friedman JH, Marras C, Tinazzi M, Comella CL.
Lancet Neurol. 2019 Sep;18(9):880-890. doi: 10.1016/S1474-4422(19)30152-8. Epub 2019 Jul 3. Review.
Pub MED

Reliability in Mandibular Movement Evaluation Using Photogrammetry in Patients With Temporomandibular Disorders.NUEVO

Andrade RM, Guimarães LR, Ribeiro AP, Pasqual Marques A, Crivello O Jr, Gonçalves de Carvalho BK, Amado João SM.
J Manipulative Physiol Ther. 2019 May;42(4):267-275. doi: 10.1016/j.jmpt.2018.11.008. Epub 2019 Jun 29.
Pub MED

Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.NUEVO

Peralta C, Biafore F, Depetris TS, Bastianello M.
Curr Neurol Neurosci Rep. 2019 Jun 29;19(8):56. doi: 10.1007/s11910-019-0966-3. Review.
Pub MED

Editorial: Update on movement disorders.NUEVO

Svenningsson P, Frucht SJ.
Curr Opin Neurol. 2019 Aug;32(4):564-565. doi: 10.1097/WCO.0000000000000709. No abstract available.
Pub MED

A dyadic group-movement therapy with adolescent girls with eating disorders.NUEVO

Dor-Haim M, Yaroslavsy A, Lev Azolay T, Dascal T, Toledano A, Latzer Y, Stein D.
J Clin Psychol. 2019 Aug;75(8):1429-1443. doi: 10.1002/jclp.22785. Epub 2019 Jun 26.
Pub MED

Gene-targeting approaches for movement disorders: recent advances.NUEVO

Kaplitt MG.
Curr Opin Neurol. 2019 Aug;32(4):566-570. doi: 10.1097/WCO.0000000000000719.
Pub MED

Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy.NUEVO

Musco S, Ruekert L, Myers J, Anderson D, Welling M, Cunningham EA.
J Clin Psychopharmacol. 2019 Jul/Aug;39(4):336-343. doi: 10.1097/JCP.0000000000001061.
Pub MED

A comparative study on oral health status in Greek preschool children with neurodevelopmental disorders with movement limitations.NUEVO

Tzouanaki A, Agouropoulos A, Kavvadia K, Papagiannoulis L.
Spec Care Dentist. 2019 Jul;39(4):421-428. doi: 10.1111/scd.12390. Epub 2019 May 27.
Pub MED

Autosomal recessive ADCY5-Related dystonia and myoclonus: Expanding the genetic spectrum of ADCY5-Related movement disorders.NUEVO

Bohlega SA, Abou-Al-Shaar H, AlDakheel A, Alajlan H, Bohlega BS, Meyer BF, Monies D, Cupler EJ, Al-Saif AM.
Parkinsonism Relat Disord. 2019 Jul;64:145-149. doi: 10.1016/j.parkreldis.2019.02.039. Epub 2019 Feb 28.
Pub MED

Oro-Pharyngeal Dysphagia in Parkinson's Disease and Related Movement Disorders.NUEVO

Kwon M, Lee JH.
J Mov Disord. 2019 Sep;12(3):152-160. doi: 10.14802/jmd.19048. Epub 2019 Sep 30.
Pub MED

The Legacy of Charles David Marsden: A Role Model in the Field of Movement Disorders.NUEVO

Zubko LEBM, Franco MKP, Meira AT, Germiniani FMB, Camargo CHF, Teive HAG.
Eur Neurol. 2019 Sep 19:1-4. doi: 10.1159/000502736. [Epub ahead of print] Review.
Pub MED

The effect of lead, restraint stress or their co-exposure on the movement disorders incidence in male mice.NUEVO

Hosseini-Sharifabad A, Naghibzadeh S, Hajhashemi V.
Res Pharm Sci. 2019 Aug;14(4):343-350. doi: 10.4103/1735-5362.263558.
Pub MED

Psychosocial correlates of prolonged postpartum depression in mothers of children with movement disorders: cross-sectional study from a paediatric developmental rehabilitation centre in Peshawar.NUEVO

Habib H, Ali W.
J Pak Med Assoc. 2019 Sep;69(9):1293-1299.
Pub MED

The Impact of Microelectrode Recording on Lead Location in Deep Brain Stimulation for the Treatment of Movement Disorders.NUEVO

Kochanski RB, Bus S, Brahimaj B, Borghei A, Kraimer KL, Keppetipola KM, Beehler B, Pal G, Metman LV, Sani S.
World Neurosurg. 2019 Aug 23. pii: S1878-8750(19)32248-X. doi: 10.1016/j.wneu.2019.08.092. [Epub ahead of print]
Pub MED

Ocular motor manifestations of movement disorders.NUEVO

Crotty GF, Chwalisz BK.
Curr Opin Ophthalmol. 2019 Aug 22. doi: 10.1097/ICU.0000000000000605. [Epub ahead of print]
Pub MED

Functional Movement Disorders in Elderly.NUEVO

Chouksey A, Pandey S.
Tremor Other Hyperkinet Mov (N Y). 2019 Jul 30;9. doi: 10.7916/tohm.v0.691. eCollection 2019.
Pub MED

Rapid eye movement sleep without atonia constitutes increased risk for neurodegenerative disorders.NUEVO

Dede HÖ, Benbir Senel G, Karadeniz D.
Acta Neurol Scand. 2019 Aug 14. doi: 10.1111/ane.13156. [Epub ahead of print]
Pub MED

Utility of the Movement Disorders Society Criteria for Progressive Supranuclear Palsy in Clinical Practice.NUEVO

Ali F, Botha H, Whitwell JL, Josephs KA.
Mov Disord Clin Pract. 2019 Jul 24;6(6):436-439. doi: 10.1002/mdc3.12807. eCollection 2019 Jul.
Pub MED

Spectrum of Movement Disorders in Patients With Neuroinvasive West Nile Virus Infection.NUEVO

Lenka A, Kamat A, Mittal SO.
Mov Disord Clin Pract. 2019 Jul 16;6(6):426-433. doi: 10.1002/mdc3.12806. eCollection 2019 Jul. Review.
Pub MED

[Deep brain stimulation for movement disorders].NUEVO

Beudel M, Oterdoom DLM, van Egmond ME, van Laar T, de Koning-Tijssen MAJ, van Dijk JMC.
Ned Tijdschr Geneeskd. 2019 Aug 6;163. pii: D3758. Dutch.
Pub MED

Focused Ultrasound and Other Lesioning Therapies in Movement Disorders.NUEVO

Walters H, Shah BB.
Curr Neurol Neurosci Rep. 2019 Aug 3;19(9):66. doi: 10.1007/s11910-019-0975-2. Review.
Pub MED

Differential movement of the sciatic nerve and hamstrings during the straight leg raise with ankle dorsiflexion: Implications for diagnosis of neural aspect to hamstring disorders.NUEVO

Bueno-Gracia E, Pérez-Bellmunt A, Estébanez-de-Miguel E, López-de-Celis C, Shacklock M, Caudevilla-Polo S, González-Rueda V.
Musculoskelet Sci Pract. 2019 Oct;43:91-95. doi: 10.1016/j.msksp.2019.07.011. Epub 2019 Jul 27.
Pub MED

Psychogenic (Functional) Movement Disorders.NUEVO

Thenganatt MA, Jankovic J.
Continuum (Minneap Minn). 2019 Aug;25(4):1121-1140. doi: 10.1212/CON.0000000000000755.
Pub MED

Movement Disorders in Children.NUEVO

Pearson TS, Pons R.
Continuum (Minneap Minn). 2019 Aug;25(4):1099-1120. doi: 10.1212/CON.0000000000000756.
Pub MED

Treatment of psychiatric disturbances in hypokinetic movement disorders.

Berardelli I, Belvisi D, Pasquini M, Fabbrini A, Petrini F, Fabbrini G.
Expert Rev Neurother. 2019 Jun 26. doi: 10.1080/14737175.2019.1636648. [Epub ahead of print]
Pub MED

Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Jellinger KA.
J Neural Transm (Vienna). 2019 Jun 24. doi: 10.1007/s00702-019-02030-y. [Epub ahead of print] Review.
Pub MED

Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension.

Dreissen YEM, Dijk JM, Gelauff JM, Zoons E, van Poppelen D, Contarino MF, Zutt R, Post B, Munts AG, Speelman JD, Cath DC, de Haan RJ, Koelman JH, Tijssen MAJ.
J Neurol Neurosurg Psychiatry. 2019 Jun 20. pii: jnnp-2018-320071. doi: 10.1136/jnnp-2018-320071. [Epub ahead of print]
Pub MED

Update on movement disorders.

Svenningsson P, Frucht SJ.
Curr Opin Neurol. 2019 Jun 18. doi: 10.1097/WCO.0000000000000709. [Epub ahead of print] No abstract available.
Pub MED

Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Jellinger KA.
J Neural Transm (Vienna). 2019 Jun 18. doi: 10.1007/s00702-019-02028-6. [Epub ahead of print] Review.
Pub MED

Roles of the M(4) acetylcholine receptor in the basal ganglia and the treatment of movement disorders.

Moehle MS, Conn PJ.
Mov Disord. 2019 Jun 18. doi: 10.1002/mds.27740. [Epub ahead of print]
Pub MED

Hyperkinetic movement disorders: Expanding the phenotype of congenital disorders of glycosylation.

Pandey S, Chouksey A.
Eur J Neurol. 2019 Jun 17. doi: 10.1111/ene.14013. [Epub ahead of print]
Pub MED

Paraneoplastic movement disorders: phenomenology, diagnosis, and treatment.

Chirra M, Marsili L, Gallerini S, Keeling EG, Marconi R, Colosimo C.
Eur J Intern Med. 2019 Jun 12. pii: S0953-6205(19)30183-9. doi: 10.1016/j.ejim.2019.05.023. [Epub ahead of print] Review.
Pub MED

Paroxysmal Movement Disorders: Recent Advances.

Xu Z, Lim CK, Tan LCS, Tan EK.
Curr Neurol Neurosci Rep. 2019 Jun 11;19(7):48. doi: 10.1007/s11910-019-0958-3. Review.
Viendo del 1 al 40 de 88 artículos
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy